These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 23668190)
1. [Current status and challenges in the treatment of multiple myeloma in China]. Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):281-2. PubMed ID: 23668190 [No Abstract] [Full Text] [Related]
2. [To attach importance to standardized diagnosis and treatment, basic and translational study on multiple myeloma in our country]. Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):283-5. PubMed ID: 23668191 [No Abstract] [Full Text] [Related]
3. Current status and future directions in the treatment of multiple myeloma. Hou J; Wang M Chin Med J (Engl); 2007 Oct; 120(19):1651-4. PubMed ID: 17935663 [No Abstract] [Full Text] [Related]
4. [The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of initial treatment]. Chen X Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):92-3. PubMed ID: 26875573 [No Abstract] [Full Text] [Related]
5. [Treatment of newly diagnosed myeloma: summary of overseas reports and current status in Japan]. Hattori Y Rinsho Ketsueki; 2010 Oct; 51(10):1499-510. PubMed ID: 20962484 [No Abstract] [Full Text] [Related]
6. [Current treatment of myeloma]. MARCHAL G; DUHAMEL G Vie Med; 1954 May; 35():25-30. PubMed ID: 13179428 [No Abstract] [Full Text] [Related]
7. Current therapy for multiple myeloma. Rajkumar SV; Gertz MA; Kyle RA; Greipp PR; Mayo Clin Proc; 2002 Aug; 77(8):813-22. PubMed ID: 12173715 [TBL] [Abstract][Full Text] [Related]
8. Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma. Gorschlüter M; Ziske C; Glasmacher A; Schmidt-Wolf IG Clin Cancer Res; 2001 Aug; 7(8):2195-204. PubMed ID: 11489792 [TBL] [Abstract][Full Text] [Related]
9. Stem cell transplantation for multiple myeloma: current status and future directions. Caldera H; Giralt S Curr Hematol Rep; 2004 Jul; 3(4):249-56. PubMed ID: 15217554 [TBL] [Abstract][Full Text] [Related]
10. Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma. Zheng D; Li J; Huang BH; Liu JR; Zou WY; Su C Chin Med J (Engl); 2012 Dec; 125(24):4454-9. PubMed ID: 23253719 [TBL] [Abstract][Full Text] [Related]
11. [Treatment for multiple myeloma: current status and future strategy in Japan]. Iida S Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921 [No Abstract] [Full Text] [Related]
12. Current role of immunotherapy in multiple myeloma. Hájek R; Adam Z; Krivanová A; Doubek M; Korístek Z; Vorlícek J Acta Med Austriaca; 1998; 25(3):79-85. PubMed ID: 9816399 [TBL] [Abstract][Full Text] [Related]
13. Current therapeutic options for multiple myeloma. Pileri A; Palumbo A; Boccadoro M Haematologica; 1996; 81(4):291-4. PubMed ID: 8870371 [No Abstract] [Full Text] [Related]
14. An update: health economics of managing multiple myeloma. Moeremans K; Annemans L Eur J Cancer; 2006 Jul; 42(11):1684-91. PubMed ID: 16781867 [TBL] [Abstract][Full Text] [Related]
15. [Current and future approaches to therapy for multiple myeloma]. Nara N Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084 [TBL] [Abstract][Full Text] [Related]
16. [Current progress in multiple myeloma and tumor vascular targeting therapy]. Wu C; Cai Z Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):363-6. PubMed ID: 23668215 [No Abstract] [Full Text] [Related]